Thomas Gidoin Joins OSE Immunotherapeutics as Chief Financial Officer
August 20, 2025 - 23:13
NANTES, France, August 20, 2025 – OSE Immunotherapeutics SA has officially announced the appointment of Thomas Gidoin as its new Chief Financial Officer. With over 15 years of extensive experience in capital markets and financial strategy, Gidoin brings a wealth of knowledge and expertise to the company’s Executive Committee.
Gidoin's background in biopharma finance is marked by a strong track record in strategic financial leadership, which he has demonstrated in both private and public sectors. His appointment is anticipated to enhance OSE Immunotherapeutics' financial governance and strategic initiatives, positioning the company for future growth and success.
The addition of Gidoin to the leadership team is seen as a pivotal move to strengthen the company's financial operations and align its strategies with the evolving landscape of the biopharmaceutical industry. Stakeholders and investors alike are looking forward to the insights and direction he will bring in his new role.
MORE NEWS
October 7, 2025 - 08:58
Key Players Reshaping the Equipment Finance Industry by 2026As the equipment finance industry approaches 2026, a dynamic shift is underway, driven by dealers, lenders, original equipment manufacturers (OEMs), and service providers. These key players are not...
October 6, 2025 - 18:50
Wall Street's Outlook on Third Quarter EarningsRecent analysis from Goldman Sachs Global Investment Research indicates that earnings for the so-called `Magnificent Seven` companies are anticipated to decelerate in the upcoming third quarter....
October 6, 2025 - 03:32
Orientum Sets Ambitious Goal for Quantum Finance Middleware by 2030Orientum, a pioneer in quantum financial algorithms, has unveiled an ambitious plan to create a comprehensive middleware platform that will integrate all quantum financial algorithms by the year...
October 5, 2025 - 21:59
Alerus Financial Corporation: A Model of Steady Growth and Dividend ReliabilityAlerus Financial Corporation has secured its place among the elite Dividend Champions, showcasing the power of consistent growth in the financial sector. The company operates through three distinct...